Sign in
CompletedNo phase

Identifying Body Awareness-related Brain Network Changes During Cognitive Multisensory Rehabilitation for Reduced Neuropathic Pain in People With Spinal Cord Injury

Key facts

Who runs it
University of Minnesota
Where
Minneapolis, United StatesSee the site
Trial code
Status
Completed
People taking part
58 people enrolled
Started
1 Sept 2020
Ended
29 Feb 2024
Type of study
Interventional, 3 groups
Treatments tested
  • Cognitive Multisensory Therapy
  • Usual Care
  • Clinical Assessment
  • Magnetic Resonance Imaging (MRI)
  • OPTIONAL: blood draw
Record updated
19 September 2024

Who can take part

Age
18 years to 70 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • SCI participants:
  • SCI of ≥ 3months
  • medically stable with paraplegia (ASIA grade A-C, who can self-transfer with some assistance)
  • neuropathic pain (>3 on the numeric pain rating scale); Able-bodied participants:
  • sex and age matched
  • healthy, able-bodied

Who cannot take part

  • MRI contra-indications (stabilizing hardware is typically MRI safe) including seizures, cognitive impairment, or other major medical complications

Where in United States

  • University of MInnesota (Brain Body Mind Lab, Division of Physical Therapy, Department of Rehab Med, Medical School)Minneapolis, United States

About the trial

What the trial wants to find out

Many adults with spinal cord injury (SCI) suffer from long-term debilitating neuropathic pain. Available treatments, including opioids, are ineffective at eliminating this pain. Based on preliminary data from Dr Morse and from Dr Van de Winckel, we have demonstrated that brain areas that are important for body awareness and pain perception (parietal operculum, insula) have weaker brain connectivity in adults with spinal cord injury than in able-bodied healthy adults and that Cognitive Multisensory Rehabilitation (CMR) can restore these networks. This study uses a delayed treatment arm phase I randomized controlled trial (RCT) for adults with SCI and a comparison of baseline outcomes in adults with SCI vs able-bodied healthy adults to address two aims:

Read full original descriptionShow less

AIM 1: Determine baseline differences in resting-state and task-based fMRI activation and connectivity in adults with SCI compared to able-bodied healthy controls.

AIM 2: Identify changes in brain activation and connectivity, as well as behavioral outcomes in pain and body awareness in adults with SCI after CMR versus standard of care.

The 3 groups in the trial

  • One time testing - able-bodied healthy adultsOther group

    Participants in this arm will be able-bodied healthy adults who will not receive an intervention. This is just a one time testing of clinical assessments (over zoom), one MRI scan, and an optional blood draw test.

    Treatment: Clinical Assessment, Magnetic Resonance Imaging (MRI), and OPTIONAL: blood draw

  • Usual Care, then Cognitive Multisensory Therapy - adults with spinal cord injury + neuropathic pain.Treatment being tested

    This is a delayed treatment arm phase I randomized controlled trial (RCT) for participants with spinal cord injury and neuropathic pain. Participants in this arm will first receive usual care and then switch over to the experimental cognitive multisensory therapy training.

    Treatment: Cognitive Multisensory Therapy, Usual Care, Clinical Assessment, Magnetic Resonance Imaging (MRI), and OPTIONAL: blood draw

  • Cognitive Multisensory Therapy, then Usual Care - adults with spinal cord injury + neuropathic pain.Treatment being tested

    This is a delayed treatment arm phase I randomized controlled trial (RCT) for participants with spinal cord injury and neuropathic pain. Participants in this arm will first receive the experimental cognitive multisensory therapy training and then switch over to usual care.

    Treatment: Cognitive Multisensory Therapy, Usual Care, Clinical Assessment, Magnetic Resonance Imaging (MRI), and OPTIONAL: blood draw

Results explained

A paper that names this trial, explained in plain words.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
19 September 2024